Aloke Finn: Silent Plaque Rupture and Healing in Coronary Artery Disease
Aloke Finn, President and Chief Scientific Officer at CVPath Institute, Inc., Clinical Professor at University of Maryland School of Medicine, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Plaque rupture is often thought of as a terminal event leading to occlusive thrombus formation and the development of acute myocardial infarction.
However, pathological studies have shown that high-grade stenoses often contain sites of multiple prior plaque ruptures, even in patients without a history of a coronary event, suggesting that silent plaque rupture may occur and be a driver of disease progression.
Here we comment on a novel study by Kakizaki et al. and Lorenz Räber published in the European Heart Journal using pooled data from the IBIS-4 and PACMAN-AMI trials which examined 783 non-culprit lesions in 336 patients with acute myocardial infarction who underwent serial multimodality intracoronary imaging at baseline and 52 weeks.
Silent plaque rupture was identified in 41 non-culprit lesions (5.2%), with visible thrombus present in only 10 of these lesions (1.3%). Among the 41 non-culprit lesions with plaque rupture at baseline, serial OCT at 52 weeks revealed that 21 (51.2%) had healed, with the healed lesions showing fibrous plaque (61.9%), layered plaque (28.6%), and thick-cap fibroatheroma (9.5%).
Their findings reinforce the concept that coronary artery disease progression is driven not only by de novo plaque growth but also by repetitive cycles of subclinical rupture and healing.
Future studies with larger sample sizes, longer follow-up periods, and systematic evaluation of the pharmacological interruption of this cycle are needed to fully elucidate the clinical implications of silent plaque rupture and to identify patients who may benefit from intensified preventive strategies before further disease progression occurs.
Nice work by our star fellow Tatsuya Shiraki!”
Title: The silent culprit: why ‘hidden’ plaque ruptures matter Get access Arrow
Authors: Tatsuya Shiraki , Aloke V Finn , Renu Virmani
Read the Full Article on European Heart Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 23, 2026, 22:46Gloria Duah: Not All ‘O Negative’ Blood Is Safe for Every Patient
-
Apr 23, 2026, 22:46Luke McLaughlin: Is Haemophilia a disability? – Vote or Share
-
Apr 23, 2026, 22:44Sonia Wolf: On My Way Back From a Very Invigorating BSH
-
Apr 23, 2026, 22:43Maximo Agustin Schiavone: ‘The Lower the Better’ Is Not a Physiological Principle
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism